The Case for Including Optic Nerve Lesions in MS Dx Criteria
Experts make the case for inclusion of optic nerve lesions as a key diagnostic measure of MS.
Stay updated with breaking news from Multiple Sclerosis Ms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts make the case for inclusion of optic nerve lesions as a key diagnostic measure of MS.
Measuring rate of force development, or explosive strength, may help identify patients with multiple sclerosis at increased risk for falls.
Lower cardiorespiratory fitness predicts increased variability in stride time in people with MS and may serve as a biomarker of function decline.
Autologous hematopoietic stem cell transplantation is linked to significantly lower relapse rates than fingolimod in patients with relapsing-remitting multiple sclerosis. But adverse events are common.
The findings of the analysis should be encouraging to physicians who may view patients with LGS as not benefiting from treatment.